Stay updated on Pembrolizumab with Chemoradiation in Laryngeal Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with Chemoradiation in Laryngeal Cancer Clinical Trial page.

Latest updates to the Pembrolizumab with Chemoradiation in Laryngeal Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe page’s displayed release/version label was updated from v3.5.2 to v3.5.3, reflecting a maintenance or software update rather than a change to the study record itself.SummaryDifference0.1%

- Check26 days agoChange DetectedWebsite revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check55 days agoChange DetectedRevision notes updated: added v3.5.0 and removed v3.4.3.SummaryDifference0.1%

- Check62 days agoChange DetectedRevision: v3.4.3 was added and v3.4.2 removed, indicating a minor version update to the page.SummaryDifference0.1%

- Check91 days agoChange DetectedThe page now shows a new revision label (Revision: v3.4.2) and the funding-notice has been removed, which are minor site-wide UI changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check98 days agoChange DetectedA site-wide funding notice was added at the top of the page. The page revision label was updated from v3.4.0 to v3.4.1.SummaryDifference0.5%

Stay in the know with updates to Pembrolizumab with Chemoradiation in Laryngeal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Chemoradiation in Laryngeal Cancer Clinical Trial page.